BioCircuit Technologies
Precision made simple
Precision made simple
BioCircuit Technologies is a medical device company that focuses on the development of tools for the repair of nerve and other tissues. Founded in 2016, the company operates in the Biotechnology, Health Care, and Manufacturing industries with its headquarters in the United States.
The company recently secured a significant $2.40M grant investment on 19 October 2023 from the National Institutes of Health. Their slogan, "Precision made simple," reflects their commitment to leveraging advanced technology to provide precise and accessible solutions in the medical field.
With their focus on addressing the need for innovative medical devices, BioCircuit Technologies stands out as a promising player in the biotechnology and healthcare sectors, attracting attention and support from notable institutions in the industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $2.40M | 1 | National Institutes of Health | 19 Oct 2023 |
| Seed Round | $9.00M | 3 |
|
27 Sep 2022 |
| Grant | $1.70M | 1 | National Institutes of Health | 04 May 2021 |
| Debt Financing | Unknown | - | 28 May 2019 | |
| Venture Round | $1.50M | - | 28 May 2019 |
No recent news or press coverage available for BioCircuit Technologies.
We care about your data, and we'd love to use cookies make your experience better.
